QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) Institutional Ownership

CUSIP: 74754R103

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
QLGN on Nasdaq
Shares outstanding
6,138,804
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FARADAY FUTURE INTELLIGENT ELECTRIC INC. 20% +150% 1,227,147 +393% FARADAY FUTURE INTELLIGENT ELECTRIC INC. 17 Nov 2025
ALPHA CAPITAL ANSTALT 2.2% 36,434 Alpha Capital Anstalt 21 Jul 2025

Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q4 0 $0 -$619,043 0
2022 Q3 2,314,772 $619,043 -$2,104 $0.27 22
2022 Q2 2,274,870 $1,294,095 -$331,488 $0.57 23
2022 Q1 2,808,708 $1,851,111 -$24,255 $0.66 28
2021 Q4 2,669,299 $2,854,181 -$109,633 $1.07 25
2021 Q3 2,777,239 $3,612,208 +$302,490 $1.30 26
2021 Q2 2,534,130 $5,043,318 +$1,183,860 $1.99 27
2021 Q1 1,892,924 $5,108,432 +$1,699,282 $2.70 28
2020 Q4 1,190,365 $3,582,482 +$1,037,310 $3.01 25
2020 Q3 810,100 $4,010,792 +$3,531,748 $4.95 15
2020 Q2 110,857 $440,635 +$440,635 $3.97 8